parapneumonic effusion
Recently Published Documents


TOTAL DOCUMENTS

220
(FIVE YEARS 58)

H-INDEX

20
(FIVE YEARS 2)

Cureus ◽  
2022 ◽  
Author(s):  
Ratnam K Santoshi ◽  
Prarthna Chandar ◽  
SushilKumar S Gupta ◽  
Yizhak Kupfer ◽  
Ory Wiesel

2021 ◽  
Vol 42 (4) ◽  
pp. 637-647
Author(s):  
Dinesh N. Addala ◽  
Eihab O. Bedawi ◽  
Najib M. Rahman

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Tadashi Hoshino ◽  
Daisuke Nishima ◽  
Mayumi Enseki ◽  
Naoki Umehara ◽  
Chie Fukasawa ◽  
...  

Author(s):  
Joanna Kirstin B Dykes ◽  
Adam Lawton ◽  
Saskia Burchett ◽  
Atul Gupta

Parapneumonic effusion is defined as the accumulation of pleural fluid associated with lung infection/pneumonia. Parapneumonic effusions can be uncomplicated or complicated. They are caused by the spread of infection and inflammation to the pleural space, and can develop into empyema thoracis—frank pus in the pleural space. Chest radiograph and thoracic ultrasound are the key imaging modalities for the diagnosis of parapneumonic effusion. Management aims are reducing inflammation and bacteria in the pleural cavity, and enabling full lung expansion. Broad-spectrum intravenous antibiotics, with the addition of chest tube drainage and fibrinolytic therapy for larger collections, are the mainstays of management. This article provides a clear, evidence-based and structured approach to the assessment and management of parapneumonic effusion/empyema thoracis in children and young people.


2021 ◽  
pp. 102217
Author(s):  
Jinkui Hao ◽  
Jiang Liu ◽  
Ella Pereira ◽  
Ri Liu ◽  
Jiong Zhang ◽  
...  

2021 ◽  
Author(s):  
Shungo Yukumi ◽  
Kei Ishimaru ◽  
Hideaki Suzuki ◽  
Masamitsu Morimoto ◽  
Mayuko Senba ◽  
...  

Abstract BackgroundThere is no evidential report about the optimal duration of antibiotic use following video-assisted thoracoscopic surgery debridement (VATS-D) in thoracic empyema (TE) or complicated parapneumonic effusion (PPE). The purpose of this study was to determine the optimal duration of antibiotic therapy after VATS-D for TE /PPE.MethodsBetween January 2011 and December 2019, total thirty-three patients (28 men, 5 women; median age 63 years) corresponding to ACCP category 3 or 4 receiving VATS-D were included in the study. Time until the body temperature (BT) was to be less than 37.5 ºC and 37.0 ºC, WBC count to be less than 10,000/μl and segmented neutrophil (seg) count to be less than 80% were retrospectively analyzed.ResultsThe median time from the onset of TE/PPE to the operation was 13 days. Pre and postoperative antibiotic had median values of 5 and 7 days, respectively. There were no hospital deaths within 30 days of the operation. Major complications occurred in 4 cases (3 respiratory failures and one celebral infarction). Median postoperative hospital stay was 14 days. Success rate in TE/PPE treatment was 88%. The median number of days until the conditions met were BT>37.5 ºC for 3 days, BT>37.0 ºC for 6 days, WBC<10,000 for 4 days and seg<80% for 7 days.ConclusionThe optimal antibiotic duration of antibiotic use after VATS-D for TE/PPE is approximately 5 days. Urgent VATS-D will shorten the total antibiotic duration.


CHEST Journal ◽  
2021 ◽  
Vol 160 (4) ◽  
pp. A304
Author(s):  
Diogo Canhoto ◽  
João Pereira ◽  
Antonio Jorge Ferreira

Author(s):  
Charisti Zampetaki ◽  
Ioanna Farakla ◽  
Eufrosini Mpriasouli ◽  
Theoni Petropoulou

Sign in / Sign up

Export Citation Format

Share Document